Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Share your knowledge and expertise with your regulatory peers by submitting an in-depth, evidence-based article focusing on key areas and emerging issues in the global regulatory landscape.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
RAPS Euro Convergence brings regulatory peers from the EU and worldwide together in one forum to gain insights and exchange ideas on the region's most pressing issues. Register today to attend 10-12 May 2021.
Registration is now open for RAPS Convergence 2021! Gather with the regulatory community 12-15 September for four days of learning, engagement, and excitement.
With contributions from more than 30 authors from seven countries, the new edition incorporates a global overview of the field and is designed to help you get the most out of your regulatory intelligence endeavors.
Regipedia is an interactive resource created to benefit RAPS members with 24/7 access to more than 2,300 regulatory terms.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 20 July 2017 | By Michael Mezher
The US Food and Drug Administration (FDA) on Thursday announced it has cleared the first magnetic resonance imaging (MRI) device intended to be used on newborns in neonatal intensive care units (NICUs).
FDA says the device, Aspect Imaging's Embrace Neonatal MRI System, was cleared via the 510(k) pathway specifically for taking images of newborn's heads, and can be used on newborns whose heads measure up to 38 centimeters in circumference and weigh between 1 and 4.5 kilograms.
According to FDA, the decision to clear the device was based on non-clinical testing using phantom images simulating an infant brain and safety data from performance testing and a review of the device's "electrical and mechanical safety measures."
"Although we can use traditional MRI scanners to image neonates, taking babies outside of the neonatal intensive care unit to MRI suites presents great challenges," said Vasum Peiris, chief medical officer for pediatrics and special populations at the Center for Devices and Radiological Health, adding that "having a system in the neonatal intensive care enables safer imaging for this vulnerable patient population.
The device also includes a temperature-controlled incubator to minimize the baby's movement during the scan, and FDA says that a baby "can typically be removed from the system in less than 30 seconds" if urgent access to the baby is required.
Because the system is fully enclosed, FDA says it does not require a safety zone or a radiofrequency shielded room, and can safely be used near patients with medical implants that are not labeled "MR Conditional" or "MR Safe".
However, the Embrace system is contraindicated for use in patients with metal or electronic implants, as FDA says the device "may cause tissue near the implant to heat or the implant to malfunction."
FDA
Tags: MRI, Magnetic Resonance Imaging, Embrace Neonatal MRI, NICU
Regulatory Focus newsletters
All the biggest regulatory news and happenings.